Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)
-
Published:2024-01
Issue:
Volume:67
Page:102372
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Fang YiORCID,
Li Jing-Xin,
Duangdany Davone,
Li Yang,
Guo Xi-Lin,
Phamisith Chanthala,
Yu Bo,
Shen Ming-Yun,
Luo Bin,
Wang Yu-Zhu,
Liu Si-Jun,
Zhao Fan-Fan,
Xu Cong-Cong,
Qiu Xu-Hui,
Yan Rong,
Gui Yu-Zhou,
Pei Rong-Juan,
Wang Jie,
Shen Haifa,
Guan Wu-Xiang,
Li Hang-Wen,
Mayxay Mayfong
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献